Multidisciplinary, three-dimensional and individualized comprehensive treatment for severe/critical COVID-19()()

Severe/critical cases account for 18–20% of all novel coronavirus disease 2019 (COVID-19) patients, but their mortality rate can be up to 61.5%. Furthermore, all deceased patients were severe/critical cases. The main reasons for the high mortality of severe/critical patients are advanced age (>60...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Third Affiliated Hospital of Sun Yat-sen University. Publishing Services by Elsevier B. V. on behalf of KeAi Communications Co., Ltd. 2020
Materias:
Practice Guideline
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7445583/
https://www.ncbi.nlm.nih.gov/pubmed/32864178
http://dx.doi.org/10.1016/j.livres.2020.08.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7445583/
https://www.ncbi.nlm.nih.gov/pubmed/32864178
http://dx.doi.org/10.1016/j.livres.2020.08.001

Ejemplares similares